Friday 6 November 2026 Export LKFT’s income statement to Excel — free account

Lakefront Biotherapeutics - Sponsored ADR

Lakefront Biotherapeutics - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 321.9% from fiscal 2024.

Revenue: −95.4%
EPS: +198.9%
Free cash flow: +18.2%

Quarter to June 2026, against a year earlier

Operating cash flow growth 3 yrs

33.46 0.10 −0.30%

Follow LKFT

Alert me

Market cap: $2.2B
P/E: 0.0×
Fwd P/E: −15.3×
Dividend yield: —
F-score: 6/9
Altman Z: 8.43
Beneish M: 0.34
Dividend safety: n/a

Overview

Lakefront Biotherapeutics - Sponsored ADR (LKFT) P/E ratio

Alert me on P/E ratio

Lakefront Biotherapeutics - Sponsored ADR has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 405× (November 2022) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LKFT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Lakefront Biotherapeutics - Sponsored ADR P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LKFT/metrics/pe-ratio">Lakefront Biotherapeutics - Sponsored ADR (LKFT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	11.6×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	80.2×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Mar 2026	0.0×	—
Mar 2025	0.0×	—
Mar 2024	13.7×	—
Sep 2023	0.0×	—
28 more quarters	Free account

Against its own ten years

Low 0.0× High 405×

Ten-year median 0.0×

Current reading's percentile 79

Company	P/E ratio
PVLA Palvella Therapeutics, Inc. compare	n/m
BHVN Biohaven Ltd. compare	n/m
LKFT Lakefront Biotherapeutics - Sponsored ADR	n/m
ZYME Zymeworks Inc. compare	n/m
SEPN Septerna, Inc. compare	n/m
VERA Vera Therapeutics, Inc. compare	n/m
IMNM Immunome, Inc. compare	n/m
AUPH Aurinia Pharmaceuticals Inc compare	6.8×
VCEL Vericel Corporation compare	77.8×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Lakefront Biotherapeutics - Sponsored ADR (LKFT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LKFT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LKFT

Stockrow Weekly